KALA BIO registers up to $250M at-the-market offering; stock at $0.78, implied market cap $278.6M

Filed July 22, 2026 · ~2 min read

Key Changes

• high

  KALA BIO has registered an at-the-market offering of up to $250 million of common stock, with sales to be made over time at prevailing market prices.

  The Offering verify on EDGAR →
• high

  At the assumed offering price of $0.78 per share (last reported sale price on July 17, 2026), the company would have 357,177,624 shares outstanding after the offering, implying a market capitalization of $278.6 million.

  The Offering verify on EDGAR →
• medium

  The company intends to use net proceeds for general corporate purposes, including working capital, with no specific allocation disclosed.

  Use of Proceeds verify on EDGAR →